Group 1 - The industry leaders are increasing their investment in AI applications for healthcare, with the number of registered models and algorithms expected to reach 101 by the end of 2024, showing a gradual upward trend [1] - Major hospitals in China, particularly top-tier hospitals, are accelerating the deployment and application of AI large models, leading to the development of specialized models for specific diseases, indicating a deepening phase of AI application in healthcare [1] - The Guotai ETF (589720) focuses on innovative drug companies in the STAR Market, tracking 30 representative high-quality companies, and has shown strong performance since the "924 market" period, outperforming the Hang Seng Hong Kong Stock Connect innovative drug index [1] Group 2 - During the market rebound from September 24, 2024, to September 30, 2025, the STAR Market innovative drug index increased by 117.04%, while the Hang Seng Hong Kong Stock Connect innovative drug index rose by 109.62%, suggesting that the STAR Market index may better capture the sector's volatility when market risk appetite improves [1]